Tumor cells have an increased nutritional demand for amino acids (AAs) to satisfy their rapid proliferation. Positron-emitting nuclide labeled AAs are interesting probes and are of great importance for imaging tumors using positron emission tomography (PET). Carbon-11 and fluorine-18 labeled AAs include the [1-11C] AAs, labeling alpha-C- AAs, the branched-chain of AAs and N-substituted carbon-11 labeled AAs. These tracers target protein synthesis or amino acid (AA) transport, and their uptake mechanism mainly involves AA transport. AA PET tracers have been widely used in clinical settings to image brain tumors, neuroendocrine tumors, prostate cancer, breast cancer, non-small cell lung cancer (NSCLC) and hepatocellular carcinoma. This review...
Routine diagnostics and treatment monitoring of brain tumors is usually based on contrast-enhanced m...
The assessment of cerebral gliomas using magnetic resonance imaging (MRI) provides excellent structu...
Routine diagnostics and treatment monitoring in patients with primary and secondary brain tumors is ...
The currently preferred radiopharmaceutical for positron emission tomography (PET) in oncology is 2-...
Amino acid metabolism PET imaging plays a very important role in metabolism molecular imaging. Amino...
Radiolabeled amino acids, their derivatives and peptides have a broad scope of application and can b...
Conventional imaging of prostate cancer has limitations related to the frequently indolent biology o...
For more than three decades, radiolabeled amino acids have been used in the field of neuro-oncology....
Malignant tumors can be detected with high sensitivity and specificity by imaging their increased me...
Positron emission tomography (PET) is an imaging technology that can detect and characterize tumors ...
Cancer progression and metastasis are driven by certain molecular features that are either non-exist...
Amino acid transport is an attractive target for oncologic imaging. Despite a high demand of cancer ...
Amino acid transport is an attractive target for oncologic imaging. Despite a high demand of cancer ...
The assessment of cerebral gliomas using magnetic resonance imaging (MRI) provides excellent structu...
The assessment of cerebral gliomas using magnetic resonance imaging (MRI) provides excellent structu...
Routine diagnostics and treatment monitoring of brain tumors is usually based on contrast-enhanced m...
The assessment of cerebral gliomas using magnetic resonance imaging (MRI) provides excellent structu...
Routine diagnostics and treatment monitoring in patients with primary and secondary brain tumors is ...
The currently preferred radiopharmaceutical for positron emission tomography (PET) in oncology is 2-...
Amino acid metabolism PET imaging plays a very important role in metabolism molecular imaging. Amino...
Radiolabeled amino acids, their derivatives and peptides have a broad scope of application and can b...
Conventional imaging of prostate cancer has limitations related to the frequently indolent biology o...
For more than three decades, radiolabeled amino acids have been used in the field of neuro-oncology....
Malignant tumors can be detected with high sensitivity and specificity by imaging their increased me...
Positron emission tomography (PET) is an imaging technology that can detect and characterize tumors ...
Cancer progression and metastasis are driven by certain molecular features that are either non-exist...
Amino acid transport is an attractive target for oncologic imaging. Despite a high demand of cancer ...
Amino acid transport is an attractive target for oncologic imaging. Despite a high demand of cancer ...
The assessment of cerebral gliomas using magnetic resonance imaging (MRI) provides excellent structu...
The assessment of cerebral gliomas using magnetic resonance imaging (MRI) provides excellent structu...
Routine diagnostics and treatment monitoring of brain tumors is usually based on contrast-enhanced m...
The assessment of cerebral gliomas using magnetic resonance imaging (MRI) provides excellent structu...
Routine diagnostics and treatment monitoring in patients with primary and secondary brain tumors is ...